about
Cyclin K inhibits HIV-1 gene expression and replication by interfering with cyclin-dependent kinase 9 (CDK9)-cyclin T1 interaction in Nef-dependent mannerSmall molecule inhibitors of the HIV-1 virulence factor, NefDifferential effects of the SR proteins 9G8, SC35, ASF/SF2, and SRp40 on the utilization of the A1 to A5 splicing sites of HIV-1 RNAHIV-1 Nef interaction influences the ATP-binding site of the Src-family kinase, HckHuman immunodeficiency virus impairs reverse cholesterol transport from macrophages.Transcriptome analysis of the whitefly, Bemisia tabaci MEAM1 during feeding on tomato infected with the crinivirus, Tomato chlorosis virus, identifies a temporal shift in gene expression and differential regulation of novel orphan genes.Human immunodeficiency virus type 1 inhibits DNA damage-triggered apoptosis by a Nef-independent mechanism.Nef from pathogenic simian immunodeficiency virus is a negative factor for vaccinia virus.Reconstitution and molecular analysis of an active human immunodeficiency virus type 1 Nef/p21-activated kinase 2 complex.Activation of p21-activated kinase 2 by human immunodeficiency virus type 1 Nef induces merlin phosphorylationThe MHC class I antigen presentation pathway: strategies for viral immune evasion.Dynamic evolution of the human immunodeficiency virus type 1 pathogenic factor, Nef.Association between virus-specific T-cell responses and plasma viral load in human immunodeficiency virus type 1 subtype C infection.Human immunodeficiency virus-1 (HIV-1)-mediated apoptosis: new therapeutic targets.Intra- and intersubtype alternative Pak2-activating structural motifs of human immunodeficiency virus type 1 NefCellular heat shock factor 1 positively regulates human immunodeficiency virus-1 gene expression and replication by two distinct pathways.Progress in the development of an HIV vaccine.HIV-1 Nef mobilizes lipid rafts in macrophages through a pathway that competes with ABCA1-dependent cholesterol efflux.Synthesis and evaluation of orally active small molecule HIV-1 Nef antagonists.Lipid metabolism in patients infected with Nef-deficient HIV-1 strain.A diacidic motif in human immunodeficiency virus type 1 Nef is a novel determinant of binding to AP-2Theoretical design of a gene therapy to prevent AIDS but not human immunodeficiency virus type 1 infectionHuman immunodeficiency virus type 1 Nef: adapting to intracellular trafficking pathways.Functional characterization of the human immunodeficiency virus type 1 Nef acidic domain.HIV-1 Nef: at the crossroadsIdentification of a novel binding site between HIV type 1 Nef C-terminal flexible loop and AP2 required for Nef-mediated CD4 downregulation.HIV-1 Nef down-modulates C-C and C-X-C chemokine receptors via ubiquitin and ubiquitin-independent mechanismHIV-1 Nef promotes the localization of Gag to the cell membrane and facilitates viral cell-to-cell transfer.Expression of Nef downregulates CXCR4, the major coreceptor of human immunodeficiency virus, from the surfaces of target cells and thereby enhances resistance to superinfection.Disassembly of human immunodeficiency virus type 1 cores in vitro reveals association of Nef with the subviral ribonucleoprotein complex.Comprehensive analysis of nef functions selected in simian immunodeficiency virus-infected macaques.Nef does not affect the efficiency of human immunodeficiency virus type 1 fusion with target cells.Intracellular versus cell surface assembly of retroviral pseudotypes is determined by the cellular localization of the viral glycoprotein, its capacity to interact with Gag, and the expression of the Nef protein.Heat shock protein 40 is necessary for human immunodeficiency virus-1 Nef-mediated enhancement of viral gene expression and replication.Alkylating HIV-1 Nef - a potential way of HIV intervention.The Nef protein of human immunodeficiency virus is a broad-spectrum modulator of chemokine receptor cell surface levels that acts independently of classical motifs for receptor endocytosis and Galphai signaling.HIV-1 Nef perturbs artificial membranes: investigation of the contribution of the myristoyl anchor.Human immunodeficiency virus type 1 Nef recruits the guanine exchange factor Vav1 via an unexpected interface into plasma membrane microdomains for association with p21-activated kinase 2 activity.Tetraspanins regulate cell-to-cell transmission of HIV-1The HIV-1 pathogenicity factor Nef interferes with maturation of stimulatory T-lymphocyte contacts by modulation of N-Wasp activity.
P2860
Q24301811-3C19C550-18F5-4472-B270-2F2C09DD1986Q27013915-50399895-C8DA-497A-B74A-3A4D31A17606Q28259926-F2C27F8D-CBD6-46D7-876E-C630F5244D24Q30010155-C8CDBADC-ABD2-4A2C-8A38-C7C980DD01A8Q33262244-85192248-C2C3-427E-8FC7-86776581932CQ33660421-31DFB96C-D26E-45F2-AAB9-C660E7817662Q33755059-FF153EB1-CC37-4C4E-93CA-EE276E170541Q33840818-48C77993-1225-46CA-B2B6-C0E0346E04E8Q34045736-A814DA3E-6A79-4FD8-81D7-BE5A0F088741Q34142952-953AF444-3592-40C8-9E16-675BBAEEC401Q34265282-2B7DF2D5-D0AB-4401-BA46-F8CD35F976FCQ34302168-D87BAA13-2D68-4CF2-B019-5619EC6B7746Q34465724-5BB52A92-2122-48FF-B52B-127401298036Q34664366-33A8CA3F-D3BB-457C-A91A-4D1B5B7E396CQ35024084-03199784-302F-4CA3-8599-58FEE6BB29DCQ35153497-F1649168-6B76-4310-91BF-51C908BBE375Q35581128-D96428BE-0A0B-4BA6-8D1C-FED5FF317956Q35839673-FCA2B274-A580-41AB-A5A6-36B511EFD672Q35916730-A6981877-DB72-4CE6-BAD0-405A1F37082AQ36421895-EB3C3075-1DA7-4994-B012-6E6CBA290CE1Q36424087-05FE3160-8783-4D18-A2C2-F4D2FD689256Q36464609-C5C96601-2215-497A-A037-56CB69212F3DQ36499676-37606E13-CA2E-4214-9F5F-3337BD38C0B9Q36898851-6B2B0C1B-B38D-48B6-A962-7F8DB8906FD5Q36926697-9547EDC9-7F04-4E5E-9A17-9A6DB7995866Q37519411-77E429DD-9BAF-4A0A-81E7-62FF1C3C67AFQ37529530-6B1A87C1-0011-47DE-BCAF-15A29E1C235CQ39118089-8760F3B7-5A61-4A2A-9BF1-75EB0084AD50Q39304735-D4D79650-0733-46D4-8876-AE47CCDCD04DQ39736736-E3980245-3AE5-42DB-92FB-C3F8B507193AQ39992284-61DD8009-6790-4A18-BB82-267271CAEB62Q40008941-A5CBB0CF-45AF-4F43-ACB9-3C87549936DEQ40367288-84989E13-3CE2-4DCC-93F8-2E9F203BA42CQ40369976-42B723D1-088E-45D3-BFBE-DD4EA2ECB5A0Q41813849-691E06D8-926D-430D-93BD-35CCB35A6B06Q41849313-345F48D9-4E7C-4DA4-9419-DC61411F2E0AQ41851046-2FAA1471-703E-4828-AAA0-D28222EF6C17Q42157622-E091292E-AC2B-4237-AA9E-C757E8786ECDQ42567174-296F29ED-DAB1-464D-B72D-E8D7BB07940EQ43756172-8A2378DD-EB17-4239-996B-FCF9C51D47DF
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Nef: agent of cell subversion.
@ast
Nef: agent of cell subversion.
@en
Nef: agent of cell subversion.
@nl
type
label
Nef: agent of cell subversion.
@ast
Nef: agent of cell subversion.
@en
Nef: agent of cell subversion.
@nl
prefLabel
Nef: agent of cell subversion.
@ast
Nef: agent of cell subversion.
@en
Nef: agent of cell subversion.
@nl
P2093
P1476
Nef: agent of cell subversion.
@en
P2093
Brenda L Fredericksen
J Victor Garcia
Vivek K Arora
P304
P356
10.1016/S1286-4579(01)01527-1
P577
2002-02-01T00:00:00Z